Rinri Therapeutics is a pioneering biotechnology startup focused on developing first-in-class cell therapies to address sensorineural hearing loss (SNHL), a condition affecting over 400 million people globally. With 90% of hearing loss cases attributed to SNHL and no existing disease-modifying treatments available for patients, Rinri's innovative approach aims to reverse SNHL by regenerating the damaged sensory cells in the cochlea, the inner ear. Established in 2018 and headquartered in the United Kingdom, Rinri has garnered significant support, including a £3.20M grant investment from Innovate UK in May 2021 and backing from prominent investors such as Boehringer Ingelheim Venture Fund (BIVF), UCB Ventures, Pioneer Group, and the University of Sheffield. With its groundbreaking technology and strategic alliances, Rinri Therapeutics is positioned to make a significant impact in the biotechnology industry and the treatment of SNHL.
Rinri Therapeutics
Pioneering the development of first in class cell therapies for sensorineural hearing loss
Sheffield, United Kingdom
15 employees
Grant
Total: $14.60M
Biotechnology
General Information
Sheffield, United Kingdom
BounceWatch is an independent company data service, not affiliated with Rinri Therapeutics. To contact Rinri Therapeutics, visit rinri-therapeutics.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Rinri Therapeutics compare?
A PDF of Rinri Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Rinri Therapeutics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Rinri Therapeutics on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United Kingdom Market
Biotechnology
About Rinri Therapeutics
Business keywords: Rinri Therapeutics, stem cell therapy, inner ear, hearing restoration, biotech, neuropathic sensorineural hearing loss, SNHL, cytoarchitecture, regenerative medicine, biomedical technology, innovative treatments, inner ear repair, audiology, biomedical engineering
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | £3.20M | 1 |
|
13 May 2021 |
| Venture Round | €10.00M | 4 |
|
20 Apr 2021 |
| Seed Round | £1.40M | 3 |
|
20 May 2019 |
Rinri Therapeutics Alternatives & Competitors
View All Alternatives
Regenerate Hair Rejuvenate Life
Decibel Therapeutics is a clinical-stage biotechnology company dedicated to discovering and developi...
Awaken your best stem cells—through machines.
FAQ About Rinri Therapeutics
Source: BounceWatch company record for Rinri Therapeutics, https://bouncewatch.com/company/rinri-therapeutics, updated 29 December 2024. When citing, please name BounceWatch and link this page.
